Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Clinical Outcome
7 results:

  • 1. A concise review on the role of BDNF-AS in human disorders.
    Ghafouri-Fard S; Khoshbakht T; Taheri M; Ghanbari M
    Biomed Pharmacother; 2021 Oct; 142():112051. PubMed ID: 34426254
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancer.
    de Mey S; Jiang H; Wang H; Engels B; Gevaert T; Dufait I; Feron O; Aerts J; Verovski V; De Ridder M
    Radiother Oncol; 2018 Jun; 127(3):361-369. PubMed ID: 29871814
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.
    Kleist B; Poetsch M
    World J Gastroenterol; 2015 Nov; 21(41):11740-7. PubMed ID: 26556999
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro.
    Sriraman SK; Geraldo V; Luther E; Degterev A; Torchilin V
    J Control Release; 2015 Dec; 220(Pt A):160-168. PubMed ID: 26497930
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimus.
    Liu Y; Starr MD; Brady JC; Rushing C; Bulusu A; Pang H; Honeycutt W; Amara A; Altomare I; Uronis HE; Hurwitz HI; Nixon AB
    Mol Cancer Ther; 2015 Apr; 14(4):1048-56. PubMed ID: 25695956
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer.
    Hale JP; Cohen DR; Maughan TS; Stephens RJ
    Br J Cancer; 2002 Jun; 86(11):1684-90. PubMed ID: 12087450
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.